Therapy Areas: Inflammatory Diseases
29 September 2023 - Peptone, a UK-based translational biophysics company, announced on Thursday that it has named Patrik Foerch, PhD as its new chief scientific officer, David Lowe, PhD as its new sen...
28 September 2023 - Evommune, Inc., a California-based biotechnology company, announced on Wednesday that it has signed a strategic collaboration with Maruho Co., Ltd., a Japan-based pharmaceutical co...
26 September 2023 - Generic and biosimilar medicines provider Sandoz, part of Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS), announced on Tuesday that the European Commission h...
26 September 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Tuesday that the US Food and Drug Administration (FDA) has accepted for Priority Review the suppleme...
21 September 2023 - AffaMed Therapeutics, a China-based global biotechnology company, announced on Wednesday that it has treated its first patient in the Phase three registrational study in China to a...
19 September 2023 - Biopharmaceutical company Pfizer Inc (NYSE: PFE) announced on Tuesday that it has received European Commission (EC) marketing authorisation for LITFULO (ritlecitinib) to treat seve...